Blog November 4, 2019
Claims Directed to Detection of Gene Variants Patent-Ineligible, Notwithstanding Mental Activity Requirement
- Person title
Genetic Technologies Ltd. v. Merial L.L.C., __ F.3d __ (Fed. Cir. Apr. 8, 2016) (Prost, DYK, Taranto) (D. Del.: Stark) (4 of 5 stars)
Federal Circuit affirms judgment that patent claims are invalid under § 101.
Genetic Technologies' claims are directed to methods for detecting alleles (i.e., alternative forms or mutations) of certain genes in a DNA sample. Central to the claims is the notion of "linkage disequilibrium"—the principle that certain DNA regions that code for proteins are "linked" or correlated in an individual's genome with certain DNA regions that do not code for protein, even though the sequences may be located far apart on the chromosome. Specifically, the claims describe amplifying and analyzing DNA regions that are non-coding, but are known to be "linked" to coding regions, so as to infer that the non-coding region is present or absent.
The Federal Circuit held that the district court did not err in finding these claims unpatentable. Applying step 1 of Alice Corp. v. CLS Bank International, 134 S. Ct. 2347, 2355 (2014), the opinion describes how the claims broadly covered "essentially all applications . . . of the law of linkage disequilibrium to the problem of detecting coding sequences of DNA." Slip op. at 9. As in Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289, 1296-97 (2012), and Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371, 1373-74, 1376 (Fed. Cir. 2015), petition for cert. filed, No. 15-1182 (U.S. Mar. 21, 2016), the central relationship at issue was a consequence of natural processes.
Applying Alice step 2, none of the additional recited elements provided an inventive concept necessary to confer patent eligibility. The claimed method's steps of "amplifying" and "analyzing" DNA were well-known when the patent application was filed. And claim 1's requirement that the DNA analysis be performed to "detect the [coding region] allele" was "a mental process step, one that provides claim 1 with a purpose but does not create the requisite inventive concept, because it merely sets forth a routine comparison that can be performed in the human mind." Slip op. at 16. The opinion reasons (citing Ariosa and In re BRCA1- & BRCA2-Based Hereditary Cancer Test Patent Litigation, 774 F.3d 755, 762-65 (Fed. Cir. 2014)), that the aspects of the patentee's claims that were potentially patent-eligible did not add enough to distinguish the claim from the underlying abstract idea. That the underlying discovery concerning linkage disequilibrium seems to have been novel was insufficient to confer patent eligibility.
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Blog August 17, 2018
En Banc Federal Circuit: Patentee's Service of Complaint, Followed by Voluntary Dismissal, Triggers IPR Clock
Blog October 5, 2017
Legal Alert: Federal Circuit Faults PTO's Approach to Claim Amendments During IPR, But Allows PTO to Try to Fix the Problem
Blog May 16, 2016
Software Claims Directed to Specific Improvements in Computer Operations May be "Non-Abstract"
Blog May 2, 2016
Corporate Residence Definition in Patent Cases Unchanged by Congressional Revisions to Venue Statute; Minimum Contacts Under Beverly Hills Fan Reaffirmed
Blog July 27, 2015
Judicial Review Available for Decision that a Patent Qualified for CBM Review; § 101 Review Appropriate in CBM Review
Blog July 8, 2015
Software Claim Addressing Concepts Long Known in Other Fields and Lacking Other Inventive Concept Is Not Patent Eligible
Blog June 18, 2015
Ordered Method Claim Does Not Bar Partly-Simultaneous Performance of Steps
Blog June 17, 2015
Claims Covering Basic Detection of Naturally-Occurring Compound, However Scientifically Significant, Not Patent Eligible
Blog June 11, 2015
Use of Generic Computer Functions to Make Traditional Economic Method More Efficient Does Not Confer Patent Eligibility
Blog March 2, 2023
Texas Patent Litigation Monthly Wrap-Up: February 2023
Blog February 10, 2023
President Biden Signs "Protecting American Intellectual Property Act of 2022" Into Law
Blog February 10, 2023
Texas Patent Litigation Monthly Wrap-Up: January 2023
Blog February 7, 2023
ITC Monthly Wrap-Up: January 2023
Blog January 17, 2023
Minnesota Patent Litigation Wrap-Up: Q4 2022
Blog January 17, 2023
Biosimilars 2022 Year in Review
Article January 4, 2023
Attorneys Daniel Tishman and Joshua Rosefelt Author "ITC Year in Review" Article in IPWatchdog
Blog January 4, 2023
Texas Patent Litigation Monthly Wrap-Up: December 2022
Blog January 3, 2023
ITC Monthly Wrap-Up: December 2022
Article December 27, 2022
Senior Principal John Dragseth Authors IPWatchdog Article "Top Federal Circuit Decisions of 2022 That No One Told You About"